Glycogen Synthase Kinase (GSK) 3β Directly Phosphorylates Serine 212 in the Regulatory Loop and Inhibits Microtubule Affinity-regulating Kinase (MARK) 2*
Glycogen Synthase Kinase (GSK) 3β Directly Phosphorylates Serine 212 in the Regulatory Loop and Inhibits Microtubule Affinity-regulating Kinase (MARK) 2*
复制标题
DOI:
10.1074/jbc.m706596200
复制
发表时间:
2008-07
影响因子:
4.8
通讯作者:
T. Timm;Kiruthiga Balusamy;Xiao-yu Li;J. Biernat;E. Mandelkow;E. Mandelkow
中科院分区:
文献类型:
--
作者:
T. Timm;Kiruthiga Balusamy;Xiao-yu Li;J. Biernat;E. Mandelkow;E. Mandelkow
MARK/Par-1, a kinase family with diverse functions particularly in inducing cell polarity, can phosphorylate microtubule-associated proteins in their repeat domain and cause their detachment from microtubules, and thereby microtubule destabilization. Because of its role in abnormal phosphorylation of the Tau protein in Alzheimer disease, we searched for regulatory kinases. MARK family kinases can be activated by phosphorylation of a conserved threonine (Thr-208 in MARK2), and inactivated by phosphorylation of a serine (Ser-212), both in the activation loop of the catalytic domain. Activation is achieved by the kinases MARKK/TAO1 or LKB1, although the inactivating kinase was unknown. We show here that GSK3β serves the role of the inhibitory kinase. Because GSK3β can also phosphorylate Tau at sites outside the repeat domain, the activation of GSK3β, and concomitant inactivation of MARK can shift the pattern of pathological phosphorylation of Tau protein in Alzheimer disease.